Hepatopulmonary syndrome.

M. B. Fallon, G. A. Abrams

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


Hepatopulmonary syndrome is caused by intrapulmonary vasodilation that leads to abnormal arterial gas exchange in the setting of liver disease or portal hypertension. It is seen in up to 15% of cirrhotics and is an increasingly common indication for liver transplantation. Testing for the presence of oxygenation abnormalities and intrapulmonary vasodilation is needed to make the diagnosis. Excess production of nitric oxide in the lung contributes to pulmonary vasodilation and may be triggered by the release of mediators from the damaged liver. No medical therapies are established as effective, and liver transplantation is the only documented curative treatment.

Original languageEnglish (US)
Pages (from-to)40-45
Number of pages6
JournalCurrent gastroenterology reports
Issue number1
StatePublished - Feb 2000

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Hepatopulmonary syndrome.'. Together they form a unique fingerprint.

Cite this